Treatment of Heroin
or Other Opiate Addiction
in Adolescents
This novel clinical research program offers science-based treatment for teenagers who are addicted to heroin or other opiate drugs, such as pain pills like Percocet and OxyContin. This program offers a unique combination of medication and behavioral treatments for teens who are addicted to opiates.
This program is entirely FREE and CONFIDENTIAL.
Eligible Teenagers:
- Ages 13-24 years
- Currently dependent on opiate drugs (heroin or pain pills)
- Males and females eligible
- Not pregnant
- Able to commute to the treatment location (subway passes available from the program)
This treatment program includes:
- Outpatient Heroin and Pain Pill Detoxification with Buprenorphine (Suboxone®) medication (1-2 months). Buprenorphine is a medication used to treat pain in the U.S. It has also been approved to treat addiction to opiate drugs in adults. Our prior research has shown that it may also be safe and effective in treating teenagers who are addicted to opiate drugs.
- Relapse prevention with Naltrexone medication (2 months). Naltrexone is an opiate blocker medication which can help prevent relapse to opiate use after a detoxification.
- Counseling and Supportive Services. Counseling includes both individual counseling sessions and optional family counseling sessions.
- Rewards for participating in the program and for remaining drug-free. Teens can earn vouchers for items they choose (such as CDs or clothes) or to do fun things (such as going to the movies, going to the gym, taking a computer class) for attending the program and for remaining opiate-free in the program.
Treatment Location:
St. Luke’s Hospital
Behavioral Science Research Unit (BSRU)
1111 Amsterdam Avenue, New York, NY, 11th Floor(On corner of Amsterdam Avenue and 114th Street)
For questions or an appointment, CALL:
866-851-2140 (Toll Free)
All research involving human participation is carefully evaluated and approved by NDRI's Institutional Review Board (IRB) before the research is allowed to begin. The IRB monitors ongoing research to ensure that it is conducted in a safe and ethical manner.